Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 1, 1999 - Issue 1
Submit an article Journal homepage
65
Views
2
CrossRef citations to date
0
Altmetric
Review

Current pharmacotherapy for inflammatory bowel disease

Brian C McKaig Division of Gastroenterology, University Hospital, Queen’s Medical Centre, Nottingham, NG7 2UH, UK. [email protected]
&
William A Stack Division of Gastroenterology, University Hospital, Queen’s Medical Centre, Nottingham, NG7 2UH, UK. [email protected]
Pages 3-14 | Published online: 24 Feb 2005

Bibliography

  • HAY JW, HAY AR: Inflammatory bowel disease: costs-of-illness. J. Clin. Gastroenterol (1992) 14(4):309–317. Cost-of-illness study of IBD in the US in 1990.
  • SASSI F, BORGONOVI E: Costo sociale delle malattie inflammatorie croniche intestinali. Argomenti Castro-enterol. Gun. (1992) 5:375–382.
  • •Cost-of-illness study of IBD in Italy in 1989/90.
  • BLOMQUIST E, EKBOM A: Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand.J. Gastroenterol. (1997) 32(10:1134–1139.
  • •Cost-of-illness study of IBD in Sweden in 1994.
  • SILVERSTEIN MD, LOFTUS EV: Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology (1999) 117:49–57.
  • HANAUER SB, COHEN RD, BECKER RV, LARSON LR, VREELAND MG: Advances in the management of Crohn's disease: economic and clinical potential of infliximab. Gun. Ther. (1998) 20 (5) :1009–1028.
  • SASSI F: The economic impact of inflammatory bowel disease. Res. Clin. Forums (1998) 20(0:191–195.
  • COHEN RD, LARSON LR, ROTH JM: Crohn's disease hospitalizations: where does the money go? Am. J. Gastroenterol. (1998) 93:1754.
  • WARD FM, BODGER K, DALY MJ, HEATLEY RV: Clinical economics review: medical management of inflamma-tory bowel disease. Aliment. Pharmacol. Ther. (1999) 13:15–25.
  • D'ALBASIO G, PACINI F, CAMARRIE E et al.: Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. Am. J. Gastroenterol (1997) 92(7):1143–1147.
  • TRALLORI G, MESSORI A: Drug treatments for maintaining remission in Crohn's disease. A lifetime cost-utility analysis. PharmacoEconomics (1997) 11(5):444–453.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.